Accelerate Diagnostics AXDX

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.05 (+4.67%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Accelerate Diagnostics (AXDX)
    Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $1.12

    • Market Cap

      $28.05 Million

    • Price-Earnings Ratio

      -0.43

    • Total Outstanding Shares

      25.04 Million Shares

    • Total Employees

      134

    • Dividend

      No dividend

    • IPO Date

      November 19, 1996

    • SIC Description

      Laboratory Analytical Instruments

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      3950 s. country club road #470, Tucson, AZ, 85714

    • Homepage

      https://www.acceleratediagnostics.com

    Historical Stock Splits

    If you bought 10 shares of AXDX before July 12, 2023, you'd have 1 share today.
    Execution DateSplit Amount
    July 12, 20231-for-10 (Reverse Split)

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Financing Activities$27.75 Million
    Net Cash Flow From Operating Activities, Continuing$-26.88 Million
    Net Cash Flow From Investing Activities$-619,000
    Net Cash Flow, Continuing$246,000
    Net Cash Flow From Financing Activities, Continuing$27.75 Million
    Net Cash Flow From Investing Activities, Continuing$-619,000

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Nonoperating Income/Loss$-14.78 Million
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0
    Benefits Costs and Expenses$64.80 Million
    Net Income/Loss$-53.45 Million
    Revenues$11.91 Million
    Preferred Stock Dividends And Other Adjustments$0

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Comprehensive Income/Loss Attributable To Parent$-54.15 Million
    Other Comprehensive Income/Loss$-54.15 Million
    Comprehensive Income/Loss$-54.15 Million

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Noncurrent Assets$4.88 Million
    Assets$32.31 Million
    Prepaid Expenses$529,000
    Other Current Assets$1.00 Million
    Cash$20.90 Million
    Liabilities And Equity$32.31 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about AXDX from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.